, Volume 38, Issue 1, pp 305–311 | Cite as

Early Administration of Cisatracurium Attenuates Sepsis-Induced Diaphragm Dysfunction in Rats

  • Jihong Jiang
  • Bin Yang
  • Guangwei Han
  • Meirong Yang
  • Shitong Li


Sepsis can often induce diaphragm dysfunction, which is associated with localized elaboration of cytokines within the diaphragm. The administration of cisatracurium has been shown to decrease the inflammatory response and to facilitate mechanical ventilation. In this study, we explored whether cisatracurium could attenuate sepsis-induced diaphragm dysfunction in rats. Animals were divided into three groups: (1) the control group: rats underwent a sham surgical procedure with cecal exposure, but the cecum was neither ligated nor punctured; (2) the CLP group: rats underwent cecal ligation and puncture (CLP) and received a continuous infusion of NaCl 0.9 %; and (3) the Cis + CLP group: rats underwent CLP and received a continuous infusion of cisatracurium. After the surgical procedure, all animals underwent controlled mechanical ventilation for 18 h. Plasma concentrations of interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), and high-mobility group box 1 (HMGB1) were measured using an enzyme-linked immunosorbent assay. Upon completion of the experimental protocol, diaphragm contractility and HMGB1 protein expression were analyzed. Impaired diaphragm contractile function, including both force-related properties and force-frequency responses, was pronounced after CLP in comparison with that observed in the control rats. Furthermore, CLP elevated serum levels of IL-6, TNF-α, and HMGB1, and induced HMGB1 protein expression in the diaphragm. In contrast, cisatracurium counteracted the sepsis-induced inflammation reaction in the diaphragm and serum and maintained diaphragm function. These data suggest that early infusion of cisatracurium attenuates sepsis-induced diaphragm dysfunction; this may be attributable to its anti-inflammatory action.


sepsis diaphragm dysfunction high-mobility group box 1 cisatracurium 



This study was supported by grants from the National Natural Science Foundation of China (81171845) and Medical Climbing Project from Songjiang Health Bureau of Shanghai (2011PD13).

Conflicts of Interest


Author’s Contribution

Jihong Jiang and Bin Yang helped conduct the study, analyze the data, and write the manuscript. Guangwei Han helped write the manuscript; Meirong Yang helped analyze the data; and Shitong Li helped design the study and write the manuscript.


  1. 1.
    Witt, N.J., D.W. Zochodne, C.F. Bolton, et al. 1991. Peripheral nerve function in sepsis and multiple organ failure. Chest 99: 176–184.CrossRefPubMedGoogle Scholar
  2. 2.
    Khan, J., T.B. Harrison, M.M. Rich, et al. 2006. Early development of critical illness myopathy and neuropathy in patients with severe sepsis. Neurology 67: 1421–1425.CrossRefPubMedGoogle Scholar
  3. 3.
    Tennila, A., T. Salmi, V. Pettila, et al. 2000. Early signs of critical illness polyneuropathy in ICU patients with systemic inflammatory response syndrome or sepsis. Intensive Care Medicine 26: 1360–1363.CrossRefPubMedGoogle Scholar
  4. 4.
    Martin, G.S., D.M. Mannino, S. Eaton, et al. 2003. The epidemiology of sepsis in the United States from 1979 through 2000. The New England Journal of Medicine 348: 1546–1554.CrossRefPubMedGoogle Scholar
  5. 5.
    Callahan, L.A., and G.S. Supinski. 2009. Sepsis-induced myopathy. Critical Care Medicine 37: S354–367.CrossRefPubMedCentralPubMedGoogle Scholar
  6. 6.
    Wang, H., O. Bloom, M. Zhang, et al. 1999. HMG-1 as a late mediator of endotoxin lethality in mice. Science 285: 248–251.CrossRefPubMedGoogle Scholar
  7. 7.
    Tsoyi, K., H.J. Jang, I.T. Nizamutdinova, et al. 2011. Metformin inhibits HMGB1 release in LPS-treated RAW 264.7 cells and increases survival rate of endotoxaemic mice. British Journal of Pharmacology 162: 1498–1508.CrossRefPubMedCentralPubMedGoogle Scholar
  8. 8.
    Tang, D., R. Kang, W. Xiao, et al. 2009. Quercetin prevents LPS-induced high-mobility group box 1 release and proinflammatory function. American Journal of Respiratory Cell and Molecular Biology 41: 651–660.CrossRefPubMedCentralPubMedGoogle Scholar
  9. 9.
    Susa, Y., Y. Masuda, H. Imaizumi, et al. 2009. Neutralization of receptor for advanced glycation end-products and high mobility group box-1 attenuates septic diaphragm dysfunction in rats with peritonitis. Critical Care Medicine 37: 2619–2624.CrossRefPubMedGoogle Scholar
  10. 10.
    Gainnier, M., A. Roch, J.M. Forel, et al. 2004. Effect of neuromuscular blocking agents on gas exchange in patients presenting with acute respiratory distress syndrome. Critical Care Medicine 32: 113–119.CrossRefPubMedGoogle Scholar
  11. 11.
    Forel, J.M., A. Roch, V. Marin, et al. 2006. Neuromuscular blocking agents decrease inflammatory response in patients presenting with acute respiratory distress syndrome. Critical Care Medicine 34: 2749–2757.CrossRefPubMedGoogle Scholar
  12. 12.
    Papazian, L., J.M. Forel, A. Gacouin, et al. 2010. Neuromuscular blockers in early acute respiratory distress syndrome. The New England Journal of Medicine 363: 1107–1116.CrossRefPubMedGoogle Scholar
  13. 13.
    Steingrub, J.S., T. Lagu, M.B. Rothberg, et al. 2014. Treatment with neuromuscular blocking agents and the risk of in-hospital mortality among mechanically ventilated patients with severe sepsis*. Critical Care Medicine 42: 90–96.CrossRefPubMedGoogle Scholar
  14. 14.
    Wichterman, K.A., A.E. Baue, and I.H. Chaudry. 1980. Sepsis and septic shock–a review of laboratory models and a proposal. The Journal of Surgical Research 29: 189–201.CrossRefPubMedGoogle Scholar
  15. 15.
    Yang, M., H. Wang, G. Han, et al. 2013. Phrenic nerve stimulation protects against mechanical ventilation-induced diaphragm dysfunction in rats. Muscle & Nerve 48: 958–962.CrossRefGoogle Scholar
  16. 16.
    Dekhuijzen, P.N., G. Gayan-Ramirez, V. de Bock, et al. 1993. Triamcinolone and prednisolone affect contractile properties and histopathology of rat diaphragm differently. The Journal of Clinical Investigation 92: 1534–1542.CrossRefPubMedCentralPubMedGoogle Scholar
  17. 17.
    Burke, R.E., D.N. Levine, P. Tsairis, et al. 1973. Physiological types and histochemical profiles in motor units of the cat gastrocnemius. The Journal of Physiology 234: 723–748.CrossRefPubMedCentralPubMedGoogle Scholar
  18. 18.
    Demoule, A., M. Divangahi, L. Yahiaoui, et al. 2006. Endotoxin triggers nuclear factor-kappaB-dependent up-regulation of multiple proinflammatory genes in the diaphragm. American Journal of Respiratory and Critical Care Medicine 174: 646–653.CrossRefPubMedGoogle Scholar
  19. 19.
    Supinski, G., D. Nethery, D. Stofan, et al. 1996. Comparison of the effects of endotoxin on limb, respiratory, and cardiac muscles. Journal of Applied Physiology 81: 1370–1378.PubMedGoogle Scholar
  20. 20.
    Lanone, S., C. Taille, J. Boczkowski, et al. 2005. Diaphragmatic fatigue during sepsis and septic shock. Intensive Care Medicine 31: 1611–1617.CrossRefPubMedGoogle Scholar
  21. 21.
    Supinski, G.S., and L.A. Callahan. 2011. Double-stranded RNA-dependent protein kinase activation modulates endotoxin-induced diaphragm weakness. Journal of Applied Physiology (1985) 110: 199–205.CrossRefGoogle Scholar
  22. 22.
    Rittirsch, D., M.S. Huber-Lang, M.A. Flierl, et al. 2009. Immunodesign of experimental sepsis by cecal ligation and puncture. Nature Protocols 4: 31–36.CrossRefPubMedCentralPubMedGoogle Scholar
  23. 23.
    Scaffidi, P., T. Misteli, and M.E. Bianchi. 2002. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 418: 191–195.CrossRefPubMedGoogle Scholar
  24. 24.
    Czura, C.J., H. Yang, C.A. Amella, et al. 2004. HMGB1 in the immunology of sepsis (not septic shock) and arthritis. Advances in Immunology 84: 181–200.CrossRefPubMedGoogle Scholar
  25. 25.
    Shindoh, C., W. Hida, Y. Ohkawara, et al. 1995. TNF-alpha mRNA expression in diaphragm muscle after endotoxin administration. American Journal of Respiratory and Critical Care Medicine 152: 1690–1696.CrossRefPubMedGoogle Scholar
  26. 26.
    Ebihara, S., S.N. Hussain, G. Danialou, et al. 2002. Mechanical ventilation protects against diaphragm injury in sepsis: interaction of oxidative and mechanical stresses. American Journal of Respiratory and Critical Care Medicine 165: 221–228.CrossRefPubMedGoogle Scholar
  27. 27.
    Sessler, C.N. 2005. Sedation, analgesia, and neuromuscular blockade for high-frequency oscillatory ventilation. Critical Care Medicine 33: S209–216.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  • Jihong Jiang
    • 1
  • Bin Yang
    • 1
  • Guangwei Han
    • 1
  • Meirong Yang
    • 1
  • Shitong Li
    • 1
  1. 1.Department of Anesthesiology, Shanghai First People’s HospitalShanghai Jiaotong University School of MedicineShanghaiPeople’s Republic of China

Personalised recommendations